Work

SGLT2 Inhibitors and False Positive Toxicology Tests

Year: 2024

Type: article

Abstract: This letter describes the case of a patient who had multiple false positive toxicology tests for urinary ethanol after the initiation of empagliflozin therapy.This case shows how a patient who undergoes toxicology testing may be harmed by use of an effective and increasingly used class of medications, sodium-glucose cotransporter 2 (SGLT2) inhibitors.

Source: New England Journal of Medicine

DOI: 10.1056/nejmc2313463

Author: Aaron L. Schwartz

Institutions: Philadelphia VA Medical Center, University of Pennsylvania

Language: English

Topic: Forensic Toxicology and Drug Analysis

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Veterans Affairs, Office of Research and Development